abstract |
Prostaglandin E2 for prevention orntreatment of lymphoblastic lymphomas.n n n The present invention fits within thenfield of molecular biology and medicine. Specifically, itnrefers to the use of prostaglandin E2 (PGE2) or any of itsnbiologically active salts, derivatives or analogs, or any ofntheir combinations, for the preparation of a medicine fornprevention or treatment of lymphoblastic lymphoma. |